Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Mark Tomai
Advertisement
Articles by Mark Tomai
The role of TLR agonists has expanded, and now the molecules can be found in a variety of non-vaccine therapeutics.
Advertisement
Latest Updated Articles
Toll-Like Receptor Agonists: Not Just for Vaccines AnymorePublished: January 2nd 2011 | Updated:
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
2
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
3
AstraZeneca Next to Agree to MFN Deal: Report
4
BioPharm Weekly News Roundup—Week of Oct. 6, 2025
5
